LONDON (Reuters) â A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.Â
FILE PHOTO: A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease (COVID-19) in Liege, Belgium, June 16, 2020. REUTERS/Yves Herman
The Medicines and Healthcare Products Regulatory Agency (MHRA) took its decision on what is known as the COPCOV trial after hydroxychloroquine was found in another British trial to have no benefit as a treatment for patients already infected with COVID-19, the disease caused by the new coronavirus.
TheÂ COPCOVÂ study was paused pending review after the treatment trial results.
It is a randomised, placebo-controlled trial that is aiming to enrol 40,000Â healthcare workers and other at-risk staffÂ around the world, and is being led by the Oxford Universityâs Mahidol Oxford Tropical Medicine Research UnitÂ (MORU) in the Thai capital, Bangkok.
U.S. President Donald Trump said in March hydroxychloroquine could be a game-changer and then said he was taking it himself, even after the U.S. regulator, the Food and Drug Administration (FDA), advised that its efficacy and safety were unproven.
The FDA later revoked emergency use authorisation for the drugs to treat COVID-19, after trials showed they were of no benefit as treatments.
But Oxford Universityâs Professor Nicholas White, who is co-leading the COPCOV trial, said studies of the drugs as a potential preventative medicine had not yet given a conclusive answer.
âHydroxychloroquine could still prevent infections, and this needs to be determined in a randomised controlled trial,â he said in a statement. âThe question whether (it) can prevent COVID-19 or not remains as pertinent as ever.â
Whiteâs team said recruitment of British health workers would resume this week, and said plans were under way for newÂ sites in Thailand and Southeast Asia,Â Africa and South America.Â Results are expected by the end of this year.
The death toll from COVID-19 surpassed half a million people on Sunday, according to a Reuters tally, with the number of cases reported globally now more than 10 million.
Reporting by Kate Kelland, editing by Paul Sandle and Timothy Heritage
Mark Zuckerberg has dismissed the threat of a punishing boycott from major advertisers pressing Facebook…
Groom dies two days after Indian wedding, 80 people infected with coronavirus
Vice President Mike Pence said hes heard very sophisticated plans to make sure the Republican…
New Yorks Broadway community had plenty of reasons to be starry-eyed going into the final…